TheraSense Bought by Abbott


By: Daniel Trecroci

On January 13, 2004, Abbott Laboratories bought TheraSense, Inc. for $1.2 billion.

The acquisition, expected to close in the second quarter, expands Abbott’s presence in the diabetes market. In addition to its line of MediSense meters, Abbott will now pick up TheraSense’s FreeStyle meter, as well as TheraSense’s FreeStyle Navigator continuous blood glucose monitor.

TheraSense and Deltec plan to launch the CozMore Insulin Technology System, which combines TheraSens’s blood glucose testing technology and insulin delivery options in a small system.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.